Mental health care gets far more interesting when you stop treating the brain like it lives in a sealed box. We connect the sharp rise in depression, anxiety, bipolar disease, PTSD, and severe mental illness to something many people never hear about in psychiatric settings: metabolic health, brain insulin resistance, and the possibility that mood symptoms can be driven by a metabolic- energy problem as opposed to a “chemical imbalance.”
We break down what the data actually shows, including how common metabolic syndrome markers are in people with major mental health diagnoses, and why the overlap matters. Then we dig into the real-world trade-offs of treatment. Medications can be lifesaving during psychosis, suicidality, or severe depression, yet some antipsychotics and antidepressants can push weight gain, fatty liver, and insulin resistance, creating a loop that keeps people stuck. We also talk through lithium’s role, its unique risk-benefit profile, and the incentives that shape prescribing.
From there, we move into ketogenic metabolic therapy and the growing research base behind it. We discuss randomized controlled trials, meta-analyses, and why confirming nutritional ketosis with blood ketones can change outcomes. Finally, we lay out the leading mechanisms: ketones as an alternative brain fuel, improved mitochondrial function, lower inflammation and oxidative stress, and shifts in neurotransmitter balance such as higher GABA and lower glutamate activity, with the gut-brain axis likely playing a supporting role.
If this sparks ideas for you or someone you care about, subscribe, share the episode, and leave a review. What part of the metabolic psychiatry model feels most convincing, and what would you want your clinician to measure first?
Ketosis as a Treatment for Severe Mental Illness- A Critical Review of Preclinical and Clinical Data
Metabolic syndrome in psychiatric patients- overview, mechanisms, and implications
Metabolic-Side-Effects-of-Psychiatric-Medications_2020
